Medisys PLC (MDY) Providing innovative solutions to the rapidly growing point-of-care diagnostic and healthcare worker safety markets. For more than 35 years, companies in the Medisys group have been advancing healthcare through development, manufacture and distribution of revolutionary medical products. The Group's mission is to become a leading worldwide provider of diagnostic systems and medical safety products enabling rapid, cost effective, on-site delivery of healthcare solutions.
For more than three decades, Medisys' primary operating unit, Hypoguard, has been devoted to advancing personal and professional healthcare management. The Company's core focus is diabetes glucose self-monitoring - a rapidly growing market of nearly $5 billion worldwide.
'Medisys-group.com'
'Hypoguard.com'

15/02/2006
Medisys reported a 'considerable improvement' in trading during the first four months of its financial year, and said the business has been cash-flow neutral for the year to date.
The medical products company said competition in its core long-term care blood glucose monitoring business has not intensified. A drop in sales amid intense competition in the market caused a fall in sales and profits last year.
Sales volumes have recovered to previous highs by cutting prices and offering various promotions, Medisys reported this morning.
Margin improvements have been achieved faster than originally anticipated, it added. The company has benefited from cost saving measures implemented in the second half of the last financial year and cost reductions for its proprietary biosensor products.
Meanwhile, it has completed the development and manufacturing scale up of the first of the new systems it has designed for Menarini, the fifth largest worldwide branded marketer of blood glucose monitoring systems.
While the launch date is not yet clear, (Around March 1) Medisys predicted that sales of the products will be one of its key revenue growth drivers in the current financial year.


LATEST ON MDY V'S ROCHE COURT CASE
MDY V'S ROCHE COURT CASE Case IS Dismissed. http://www.moneyam.com/InvestorsRoom/posts.php?tid=8721#lastread
My apologies for any one that was on MDY it looks like we have been stitched up like a kipper the sale of Hypoguard blood glucose monitoring business at that price looks like an sp of 3p against the close of 6.4p what can I say no one could have seen this coming a total sell out and that is what I have done.

Did you see updated news on court case ?

moneyman
Yes its on the cc page.
http://www.moneyam.com/InvestorsRoom/posts.php?tid=8721#lastread

moneyman
Sorry moneyman I just had a look and it was you that put it on the cc page I thought it was mp, moneyplus

just added a few today in the hope they've hit bottom!!

mp
We could see a large hike in the sp when the end of the cc becomes official.

A nice 3m buy at the end of trade we havn't seen that for a while.

Maybe MDY Management can now look to the tatters that was their business - maybe to finding some replacement products to replace the needle-business that was so much - and then so little.
The sp stood about 7p last AGM (early 2005, )
It is now about 2p
That's a loss of 66% - grief that says a lot of folk wanted out.
Come-on MDY- - - find new products - ou could improve investor confidence by having a 1-year halt on all share-options and Director incentives -( they don't work )- what's wrong with "pride in one's work?"
I hold MDY.

hangon
Keep hanging on it will come good in the end.

See ADVFN MDY thread is over-run by idiots !

moneyman
I have seen it; the thread is just a drinking hole for them to visit.

20/01/2005 Roche has ask for another two week extension.

http://www.moneyam.com/InvestorsRoom/posts.php?tid=8721#lastread

The consensus of opinion from other b/boards is that MDY have it in the bag, Im sitting on the fence till we get an rns I wouldnt want to ramp but keep an eye on this Monday morning.

driver are you sure they are not agreeing to mutually settle--therefore no winners but at least a resolution.

mp
That may be the case as you say at least it will be an end to it.

Good news on the court case posted over at ADVFN this weekend.

moneyman
Thanks mm its on the cc page.
http://www.moneyam.com/InvestorsRoom/posts.php?tid=8721#lastread

When they were up they were up and when they were down they were down.

.

STIPULATION OF DISMISSAL WITH PREJUDICE
A settlement having been reached, the above-identified parties, through their
undersigned attorneys, hereby stipulate and agree pursuant to Fed. Rule Civ. P. 41 that the Plaintiffs Amended Complaint and the Defendants Amended Counterclaims in this case be dismissed with prejudice. The parties further stipulate that the Court shall retain jurisdiction over any disputes arising out of or related to the parties Confidential Settlement Agreement. Each of these parties will bear its own costs and attorneys fees.
Respectfully submitted,
s/Lynn C. Tyler
Donald E. Knebel
Larry A. Mackey
Lynn C. Tyler
Paul B. Hunt
Helen K. Geib
BARNES & THORNBURG LLP
11 South Meridian Street
Indianapolis, Indiana 46204
s/Robert W. Busby
Robert W. Busby
W. Jackson Matney, Jr.
Baker & McKenzie LLP
815 Connecticut Avenue, N.W.
Washington, DC 20006

It looks like its finely over. case be dismissed.

2/02/2006 21hrs
324
STIPULATION OF DISMISSAL WITH PREJUDICE
A settlement having been reached, the above-identified parties, through their
undersigned attorneys, hereby stipulate and agree pursuant to Fed. Rule Civ. P. 41 that the Plaintiffs Amended Complaint and the Defendants Amended Counterclaims in this case be dismissed with prejudice. The parties further stipulate that the Court shall retain jurisdiction over any disputes arising out of or related to the parties Confidential Settlement Agreement. Each of these parties will bear its own costs and attorneys fees.
Respectfully submitted,
s/Lynn C. Tyler
Donald E. Knebel
Larry A. Mackey
Lynn C. Tyler
Paul B. Hunt
Helen K. Geib
BARNES & THORNBURG LLP
11 South Meridian Street
Indianapolis, Indiana 46204
s/Robert W. Busby
Robert W. Busby
W. Jackson Matney, Jr.
Baker & McKenzie LLP
815 Connecticut Avenue, N.W.
Washington, DC 20006

325
This matter came before the Court upon the Stipulation of Dismissal of the plaintiffs,
Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., and Corange International,
Ltd. and the defendants, Apex Biotechnology Corporation, Hypoguard USA, Inc., and Medline
Industries, Inc. The Court, being duly advised, it is hereby
ORDERED that the Plaintiffs Amended Complaint and the Defendants Amended
Counterclaims are DISMISSED WITH PREJUDICE, with each party to bear its own costs and
attorneys fees.
IT IS FURTHER ORDERED THAT the Court shall retain jurisdiction over any
disputes arising out of or related to the parties Confidential Settlement Agreement.
SO ORDERED.